Boston Scientific (BSX) PT Lowered to $42 at Credit Suisse
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $48.30 +3.12%
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Credit Suisse analyst Matt Miksic lowered the price target on Boston Scientific (NYSE: BSX) to $42.00 (from $46.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Reliance Industries (RELIANCE:IN) PT Raised to INR1,710 at Jefferies
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- Xior Student Housing NV (XIOR:BB) PT Lowered to EUR37 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
